BCL2L1 and cancer: It has recently become clear that unbalanced RNA splicing of certain genes is associated with malignant properties of human cancer cells [11], [12], [13], e.g., resistance to chemotherapy and radiotherapy with BCL-X, onco-developmentally undifferentiated state with HIPK3, and invasive metastatic potentials with RON/MISTR1.